Termination Decision Document | Jan 16, 2019 | PAPER | BOARD |
Order Authorizing the Filing of a Joint Motion to Terminate | Jan 9, 2019 | PAPER | BOARD |
Ex. 1047 | Jan 9, 2019 | EXHIBIT | PETITIONER |
Joint Motion to Terminate Proceeding Pursuant to 35 U.S.C. ¿¿ 317(a) | Jan 9, 2019 | PAPER | PETITIONER |
Ex. 1048 | Jan 9, 2019 | EXHIBIT | PETITIONER |
Joint Request that Settlement Agreements be Treated as Business Confidential Information and Be Kept Separate | Jan 9, 2019 | PAPER | PETITIONER |
DECISION - Granting Petitioner¿¿¿s Motion to Correct a Typographical or Clerical Mistake
37 C.F.R. ¿¿ 42.104(c) | Dec 14, 2018 | PAPER | BOARD |
ORDER - Granting Petitioner¿¿¿s Motion to Submit Supplemental Information
37 C.F.R. ¿¿ 42.123(a) | Dec 14, 2018 | PAPER | BOARD |
Opposition to Motion to Correct | Dec 3, 2018 | PAPER | PATENT OWNER |
Opposition to Motion to Submit Supplemental Information | Dec 3, 2018 | PAPER | PATENT OWNER |
Petitioner Mylan Pharmaceuticals Inc.¿¿¿s Updated List of Exhibits | Nov 29, 2018 | PAPER | PETITIONER |
Ex. 1046 - Nov. 16, 2018 Telephonic Hearing Transcript | Nov 29, 2018 | EXHIBIT | PETITIONER |
Petitioner's Motion to Correct a Typographical or Clerical Mistake in the Petition Under 37 C.F.R. 42.104(c) | Nov 26, 2018 | PAPER | PETITIONER |
Petitioner Mylan Pharmaceuticals Inc.'s Updated List of Exhibits | Nov 26, 2018 | PAPER | PETITIONER |
Ex. 1043 - Rudnic, 4th edition, Modern Pharmaceutics | Nov 26, 2018 | EXHIBIT | PETITIONER |
Petitioner's Motion to File Supplemental Information Pursuant to 37 C.F.R. 42.123(a) | Nov 26, 2018 | PAPER | PETITIONER |
Ex. 1042 - Rudnic, 3rd edition, Modern Pharmaceutics | Nov 26, 2018 | EXHIBIT | PETITIONER |
Ex. 1044 - Second Supplemental Declaration of Kinam Park, Ph.D. | Nov 26, 2018 | EXHIBIT | PETITIONER |
Ex. 1045 - Declaration of Karen L. Carroll | Nov 26, 2018 | EXHIBIT | PETITIONER |
Order - Authorizing Motion to Correct a Clerical or Typographical Mistake Authorizing Motion to File Supplemental Information - 37 CFR 42.104(c), 42.123(a) | Nov 20, 2018 | PAPER | BOARD |
PO Updated Mandatory Notices | Nov 16, 2018 | PAPER | PATENT OWNER |
Notice of Deposition of Kinam Park | Nov 16, 2018 | PAPER | PATENT OWNER |
Petitioner's Notice of Service of Supplemental Evidence | Nov 9, 2018 | PAPER | PETITIONER |
PO's Objections to Evidence | Oct 29, 2018 | PAPER | PATENT OWNER |
Institution of Inter Partes Review
35 U.S.C. § 314 | Oct 15, 2018 | PAPER | BOARD |
SCHEDULING ORDER | Oct 15, 2018 | PAPER | BOARD |
Patent Owners' Updated Mandatory Notice | Oct 9, 2018 | PAPER | PATENT OWNER |
ORDER Conduct of the Proceeding | Sep 17, 2018 | PAPER | BOARD |
Petitioner's Updated Mandatory Disclosures | Sep 7, 2018 | PAPER | PETITIONER |
Order - Conduct of the Proceeding - 37 CFR 42.5 | Sep 6, 2018 | PAPER | BOARD |
Petitioner Mylan Pharmaceuticals Inc.'s Updated List of Exhibits | Sep 6, 2018 | PAPER | PETITIONER |
Ex. 1036 - Telephonic Hearing Transcript | Sep 6, 2018 | EXHIBIT | PETITIONER |
Patent Owners' Preliminary Response | Jul 18, 2018 | PAPER | PATENT OWNER |
Sumeet S. Chugh et al., Worldwide Epidemiology of Atrial Fibrillation | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
John A. Heit, Epidemiology of venous thromboembolism | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
Jeffrey Weitz - The 50-year quest to replace warfarin (2011) | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
Larry Husten, Pfizer and Bristol¿¿¿s ARISTOTLE Study Finds the Golden Mean of Anticoagulation | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
Alpesh Amin et al., Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Compared to Warfarin Among Non-Valvular Atrial Fibrillation Patients in the US Medicare Population | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
Ergene Oktay - Will NOACs become the new standard of care in anticoagulation therapy? | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
Pancras C. Wong et al., Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
Coal. for Affordable Drugs IX LLC v. Bristol-Myers Squibb Co., Decision Denying Institution of Inter Partes Review | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
U.S. Patent Application Publication No. 2012/0087978 to Richard G. Nause (published Apr. 12, 2012) | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
TRENTAL (pentoxifylline) Package Insert (July 2010) | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
COPEGUS (ribavirin) Package Insert (August 2015) | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
EPIVIR (Lamivudine) Package Insert (April 2018) | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
HIVID (zalcitabine) Package Insert (September 2001) | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
ZERIT (stavudine) Package Insert (December 2017) | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
ELIQUIS (apixaban) Package Insert (June 2018) | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
Modern Pharmaceutics, Table of Contents (Gilbert S. Banker & Christopher T. Rhodes Eds., 4th ed. 2002) | Jul 18, 2018 | EXHIBIT | PATENT OWNER |
Patent Owners' Updated Mandatory Notice | Jun 13, 2018 | PAPER | PATENT OWNER |
Updated Pfizer Power of Attorney | Jun 13, 2018 | PAPER | PATENT OWNER |
Updated Bristol-Myers Squibb Power of Attorney | Jun 13, 2018 | PAPER | PATENT OWNER |
EXPUNGED | Jun 12, 2018 | PAPER | BOARD |
Granting Patent Owner's Motion for Pro Hac Vice Admission of Mr. Kevin S. Prussia | Jun 12, 2018 | PAPER | BOARD |
Granting Patent Owner's Motion for Pro Hac Vice Admission of Ms. Amy K. Wigmore | Jun 12, 2018 | PAPER | BOARD |
Conduct of the Proceeding | Jun 12, 2018 | PAPER | BOARD |
PATENT OWNERS' MOTION FOR ADMISSION
PRO HAC VICE OF KEVIN S. PRUSSIA | May 16, 2018 | PAPER | PATENT OWNER |
Declaration of Kevin M. Prussia | May 16, 2018 | EXHIBIT | PATENT OWNER |
PATENT OWNERS' MOTION FOR ADMISSION
PRO HAC VICE OF AMY K. WIGMORE | May 16, 2018 | PAPER | PATENT OWNER |
DECLARATION OF AMY K. WIGMORE IN SUPPORT OF
MOTION FOR ADMISSION PRO HAC VICE | May 16, 2018 | EXHIBIT | PATENT OWNER |
Notice of Accepting Corrected Petition | Apr 26, 2018 | PAPER | BOARD |
Patent Owner Mandatory Notice | Apr 25, 2018 | PAPER | PATENT OWNER |
Pfizer Inc. Power of Attorney | Apr 25, 2018 | PAPER | PATENT OWNER |
Bristol-Myers Squibb Company Power of Attorney | Apr 25, 2018 | PAPER | PATENT OWNER |
Corrected Exhibit List | Apr 20, 2018 | PAPER | PETITIONER |
Notice of Accord Filing Date | Apr 19, 2018 | PAPER | BOARD |
Ex. 1003 - File history of 945 patent | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1005 - Pinto | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1006 - WO2010147978 | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1007 - U.S. Patent No. 6,967,208 | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1011 - Stegemann | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1012 - WO2010003811 | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1013 - Augsberger 2002 | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1001 - 945 Patent | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1004 - Carreiro | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1008 - U.S. Publication No. 2006.01060841 | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1009 - Ashford | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1010 - Rudnic | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1014 - U.S. Patent No. 5,314,506 | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1015 - FDA Guidance - Dissolution Testing | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1016 - 2004 USP 27 NF 22 - General Notices and Requirements | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1017 - U.S. Provisional Application 61.308,056 | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1018 - Surgeon General Call to Action | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1019 - Beckman | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1021 - Remko | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1022 - Ungell | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1023 - Tong | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1025 - Brown | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1026 - Gong | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1027 - USP XX, p. 1121 | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1028 - Diebold | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1029 - Dahan | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1030 - Shah | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1031 - Dressman | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1033 - Handbook of Pharmaceutical Excipients | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1034 - Hom | Apr 5, 2018 | EXHIBIT | PETITIONER |
Power of Attorney | Apr 5, 2018 | PAPER | PETITIONER |
Ex. 1020 - Cohen | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1024 - Yu | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1032 - Kramer | Apr 5, 2018 | EXHIBIT | PETITIONER |
Ex. 1035 Remington's | Apr 5, 2018 | EXHIBIT | PETITIONER |
IPR Petition for the 945 Patent | Apr 5, 2018 | PAPER | PETITIONER |
Ex. 1002 - Declaration of Dr. Kinam Park | Apr 5, 2018 | EXHIBIT | PETITIONER |